Literature DB >> 31452228

How the Membrane Attack Complex Damages the Bacterial Cell Envelope and Kills Gram-Negative Bacteria.

Dennis J Doorduijn1, Suzan H M Rooijakkers1, Dani A C Heesterbeek1.   

Abstract

The human immune system can directly lyse invading micro-organisms and aberrant host cells by generating pores in the cell envelope, called membrane attack complexes (MACs). Recent studies using single-particle cryoelectron microscopy have revealed that the MAC is an asymmetric, flexible pore and have provided a structural basis on how the MAC ruptures single lipid membranes. Despite these insights, it remains unclear how the MAC ruptures the composite cell envelope of Gram-negative bacteria. Recent functional studies on Gram-negative bacteria elucidate that local assembly of MAC pores by surface-bound C5 convertase enzymes is essential to stably insert these pores into the bacterial outer membrane (OM). These convertase-generated MAC pores can subsequently efficiently damage the bacterial inner membrane (IM), which is essential for bacterial killing. This review summarizes these recent insights of MAC assembly and discusses how MAC pores kill Gram-negative bacteria. Furthermore, this review elaborates on how MAC-dependent OM damage could lead to IM destabilization, which is currently not well understood. A better understanding on how MAC pores kill bacteria could facilitate the future development of novel strategies to treat infections with Gram-negative bacteria.
© 2019 The Authors. BioEssays Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  C5 convertases; Gram-negative bacteria; complement; membrane attack complexes; serum bactericidal activities

Mesh:

Substances:

Year:  2019        PMID: 31452228     DOI: 10.1002/bies.201900074

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  7 in total

Review 1.  More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.

Authors:  Elisabet Bjanes; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-27       Impact factor: 11.056

Review 2.  Ancient but Not Forgotten: New Insights Into MPEG1, a Macrophage Perforin-Like Immune Effector.

Authors:  Charles Bayly-Jones; Siew Siew Pang; Bradley A Spicer; James C Whisstock; Michelle A Dunstone
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

3.  Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores.

Authors:  Dennis J Doorduijn; Dani A C Heesterbeek; Maartje Ruyken; Carla J C de Haas; Daphne A C Stapels; Piet C Aerts; Suzan H M Rooijakkers; Bart W Bardoel
Journal:  PLoS Pathog       Date:  2021-11-09       Impact factor: 7.464

4.  Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5.

Authors:  Dennis J Doorduijn; Marie V Lukassen; Marije F L van 't Wout; Vojtech Franc; Maartje Ruyken; Bart W Bardoel; Albert J R Heck; Suzan H M Rooijakkers
Journal:  Elife       Date:  2022-08-10       Impact factor: 8.713

5.  The lytic polysaccharide monooxygenase CbpD promotes Pseudomonas aeruginosa virulence in systemic infection.

Authors:  Satoshi Uchiyama; Helen Masson; Fatemeh Askarian; Henrik Vinther Sørensen; Ole Golten; Anne Cathrine Bunæs; Sophanit Mekasha; Åsmund Kjendseth Røhr; Eirik Kommedal; Judith Anita Ludviksen; Magnus Ø Arntzen; Benjamin Schmidt; Raymond H Zurich; Nina M van Sorge; Vincent G H Eijsink; Ute Krengel; Tom Eirik Mollnes; Nathan E Lewis; Victor Nizet; Gustav Vaaje-Kolstad
Journal:  Nat Commun       Date:  2021-02-23       Impact factor: 14.919

Review 6.  Control of Blood Coagulation by Hemocompatible Material Surfaces-A Review.

Authors:  Janna Kuchinka; Christian Willems; Dmitry V Telyshev; Thomas Groth
Journal:  Bioengineering (Basel)       Date:  2021-12-15

7.  Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals.

Authors:  Emma Ispasanie; Lukas Muri; Anna Schubart; Christine Thorburn; Natasa Zamurovic; Thomas Holbro; Michael Kammüller; Gerd Pluschke
Journal:  Front Immunol       Date:  2021-10-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.